Patent Foramen Ovale and Diving
PDF
Cite
Share
Request
Review
VOLUME: 7 ISSUE: 1
P: 58 - 64
January 2019

Patent Foramen Ovale and Diving

Bezmialem Science 2019;7(1):58-64
1. Çanakkale Onsekiz Mart University Faculty of Medicine, Undersea and Hyperbaric Medicine, Çanakkale, Turkey
No information available.
No information available
Received Date: 19.07.2017
Accepted Date: 26.02.2018
Publish Date: 28.02.2019
PDF
Cite
Share
Request

ABSTRACT

Although patent foramen ovale (PFO) was anatomically depicted in 1513 by Leonardo da Vinci and described as a thromboembolism route in 1877, it has been ignored for a long time as a potential way to produce pathological conditions. The unifying hypothesis associated with multiple clinical issues, such as cryptogenic stroke, migraine and decompression sickness is that a particle, inert gas bubbles or chemical substance in the venous circulation bypasses the lungs and enters to the systemic circulation via PFO. In this review, current data on the status of PFO in diving medicine are discussed.

Keywords:
Patent foramen ovale, diving, decompression sickness

Introduction

Foramen ovale is an interatrial connection that enables rapid transiting of umbilical blood to the brain and vital organs without any further oxygen loss during intrauterine period. After birth, the foramen ovale flap (septum primum) is closed on the septum secundum, physiologically when pulmonary vascular resistance and right atrium pressure drop. Fusion, which begins with contact, is completed irreversibly, in the first two years of life. Foramen ovale remains patent in 25% of the population (1,2). The patent foramen ovale (PFO) was drawn and depicted by Leonardo Da Vinci in the form of a “channel” centuries after the physiological closure was defined by Galen. Use of the term “channel” is unique in that century in terms of predicting the complex structure of PFO pathophysiology and pointing out that it is more than just a simple hole (3).

While individuals with PFO are generally identified incidentally in autopsies, antemortem diagnosis is often made during the etiological investigations of clinical pictures associated with PFO. In an autopsy study consisting of 965 people, PFO sizes were measured between 1-19 mm (4.9 mm on average) and the mean size was 3.4 mm in the first decade and was 5.8 mm in the tenth decade. This is interpreted as the fact that small-size PFOs are closed over time and that large-sized ones remain open (4). The combining hypothesis for the association of PFO with numerous clinical conditions such as cryptogenic stroke, migraine, sleep apnea, pulmonary edema due to high altitude, platypnea-orthodeoxia, decompression sickness (DCS), is based on the passage of a particulate, gas bubble, or chemical substance in venous circulation to systemic circulation without being exposed to the lungs through a right-to-left shunt. The left atrium pressure is higher than the right atrium, which prevents passage by holding down the septum primum flap to septum secundum. Even if the flap is partially open, the blood flow will be from left to right. However, daily activities such as lifting, coughing, vomiting, and pushing which increase intrathoracic (ITP) and intraabdominal pressure may reverse the interatrial pressure gradient, creating a temporary right-to-left shunt. One of the most effective methods is an extended and forced Valsalva maneuver (VM) (1,2,5). The maneuver, originally described in 1704 by Mario Antonio Valsalva in detail in his work “De Aure Humana Tractatus” (Treatise on the Human Ear), is simply an effort of forced expiration against a closed airway. In order to prevent middle ear barotrauma, the VM is frequently used during diving and hyperbaric oxygen treatment. The response to the maneuver is related to the duration of the maneuver, the level of strain, the position of the body and the respiratory pattern (5). Astonishingly, while gentle VMs during diving do not increase the ITP at all, much larger increases are observed if maneuver is performed during challenging and crouching (6).

Another issue about PFO-mediated transition that has recently been discussed is the blood flow dynamics in the right atrium and its relationship with fossa ovalis. At the right atrium, the currents from the caval veins do not collide head to head, they turn forward and contribute to the rotation of the blood in the clockwise. This filling pattern associated with directing the atrial volume towards the tricuspid valve entry is extremely important in maintaining the continuous activity of the heart with minimal energy. This vortex formed at the right atrium entrance is thought to remove the blood out of PFO which carries the majority of thrombus material, bubble, vasoactive chemicals and which is coming with the inferior caval current directed at almost to the fossa ovalis at the beginning which (7,8).

The PFO-mediated shunt can be determined by different echocardiographic techniques, including transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), and transcranial Doppler (TCD). Having superior image resolution, having ability to distinguish shunt localization, having ability to define morphology, presence of accompanying defects, number and size of these defects, completeness of septum apart from defect and the presence of anatomic structures that will affect the placement of the device and visualizing the three-dimensional appearance of PFO in mind make TEE the gold standard in the diagnosis of PFO (1,2,9,10). However, it comes after TTE or TCD in the evaluation hierarchy because it is a semi-invasive procedure with well defined staff training criteria, it has life-threatening complications such as esophagus hemorrhage, perforation and it is contraindicated in patients with severe bleeding risk. TTE is the most frequently used initial screening test because of its low cost, non-invasive nature and easy accessibility (9,10).

The most common contrast used in echocardiography routine is saline which is agitated by mixing with air. Air bubbles are cleared as they pass through the lungs, and those who can pass are dissolved in the blood. Because tissues are not supersaturated with nitrogen, DCS symptoms are not observed even if there is a high bubble passage (11). However, during echocardiographic studies with contrast agents, for safety reasons, oxygen should be available and the diver should not have dived within the last 24 hours (6). It has been shown that TCD has similar sensitivity to shunt detection, but it fails to differentiate cardiac and pulmonary localizations (2,9,10).

Provocative maneuvers that increase the ITP, also significantly increase the sensitivity of TTE and TEE. Because conscious sedation is applied during TEE, the effect to be achieved with a challenging VM is tried to be performed by abdominal compression. The timing of the bubbles in the left heart is very important in the separation of intracardiac and transpulmonary shunts. In the presence of a shunt at the cardiac level, the bubbles are expected to be seen in the left heart in three cardiac cycles. In the presence of a large pulmonary shunt, it should be noted that contrast in the left heart can be seen in three cardiac cycles, and a more detailed imaging of the shunt to clarify localization should be performed with TEE. The systems used in grading are subjective and are usually based on semi-quantitative factors that focus on the number of bubbles seen in the left atrium. Therefore, there is no widely accepted schema (9,10). Another important point is the localization of contrast injection. Femoral injections have been shown to be more effective than conventional brachial injections. This effect is related to the blood flow dynamics in the right atrium and its relation with PFO, which is described above, and to the rapid bolus and shorter venous transit time provided by a larger diameter femoral catheter, and thus to the reduction of the dissolved bubbles (9,12).

References

1
Tobis J, Shenoda M. Percutaneous treatment of patent foramen ovale and atrial septal defects. J Am Coll Cardiol 2012;60:1722-32.
2
Mojadidi MK, Christia P, Salamon J, Liebelt J, Zaman T, Gevorgyan R, et al. Patent foramen ovale: Unanswered questions. Eur J Intern Med 2015;26:743-51.
3
Rigatelli G, Zuin M. Leonardo da Vinci and patent foramen ovale: An historical perspective. Int J Cardiol 2016;222:826.
4
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
5
Pstras L, Thomaseth K, Waniewski J, Balzani I, Bellavere F. The Valsalva manoeuvre: physiology and clinical examples. Acta Physiol (Oxf) 2016;217:103-19.
6
Wendling J, Balestra C, Germonpré P. Is screening for patent foramen ovale feasible? South Pacific Underwater Medicine Society (SPUMS) Journal 2001;31:85-9.
7
Balestra C, Germonpré P. Correlation between Patent Foramen Ovale, Cerebral “Lesions” and Neuropsychometric Testing in Experienced Sports Divers: Does Diving Damage the Brain? Front Psychol 2016;11:696.
8
Parikh JD, Kakarla J, Keavney B, O’Sullivan JJ, Ford GA, Blamire AM, et al. 4D flow MRI assessment of right atrial flow patterns in the normal heart - influence of caval vein arrangement and implications for the patent foramen ovale. PLoS One 2017;12:e0173046.
9
Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2013;26:921-64.
10
Rana BS, Thomas MR, Calvert PA, Monaghan MJ, Hildick-Smith D. Echocardiographic evaluation of patent foramen ovale prior to device closure. JACC Cardiovasc Imaging 2010;3:749-60.
11
Wilmshurst PT. The role of persistent foramen ovale and other shunts in decompression illness. Diving Hyperb Med 2015;45:98-104.
12
Saura D, García-Alberola A, Florenciano R, de la Morena G, Sánchez-Muñoz JJ, Soria F, et al. Alternative explanations to the differences of femoral and brachial saline contrast injections for echocardiographic detection of patent foramen ovale. Med Hypotheses 2007;68:1378-81.
13
Vann RD, Butler FK, Mitchell SJ, Moon RE. Decompression illness. Lancet 2011;377:153-64.
14
Papadopoulou V, Eckersley RJ, Balestra C, Karapantsios TD, Tang MX. A critical review of physiological bubble formation in hyperbaric decompression. Adv Colloid Interface Sci 2013;191:22-30.
15
Toklu AS, Cimsit M, Yildiz S, Uzun G, Korpinar S, Sezer H, et al. Decompression sickness cases treated with recompression therapy between 1963 and 1998 in Turkey: review of 179 cases. Undersea Hyperb Med 2014;41:217-21.
16
Ljubkovic M, Marinovic J, Obad A, Breskovic T, Gaustad SE, Dujic Z. High incidence of venous and arterial gas emboli at rest after trimix diving without protocol violations. J Appl Physiol 2010;109:1670-4.
17
Ljubkovic M, Dujic Z, Møllerløkken A, Bakovic D, Obad A, Breskovic T, et al. Venous and arterial bubbles at rest after no-decompression air dives. Med Sci Sports Exerc 2011;43:990-5.
18
Golding FC, Griffiths P, Hempleman HV, Paton WD, Walder DN. Decompression sickness during construction of the Dartford Tunnel. Br J Ind Med 1960;17:167-80.
19
Dunford RG, Vann RD, Gerth WA, Pieper CF, Huggins K, Wachholz C, et al. The incidence of venous gas emboli in recreational diving. Undersea Hyperb Med 2002;29:247-59.
20
Madden D, Ljubkovic M, Dujic Z. Intrapulmonary shunt and SCUBA diving: another risk factor? Echocardiography 2015;32(Suppl 3):S205-10.
21
Wilmshurst PT, Ellis BG, Jenkins BS. Paradoxical gas embolism in a scuba diver with an atrial septal defect. BMJ 1986;293:1277.
22
Cohnheim J. Vorlesungen uber allgemeine Pathologie-ein Handbuch fur Aerzte und Studirende, Erste Ausgabe. Berlin, Hirschwald, 1877.
23
Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52.
24
Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-2.
25
Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-51.
26
Bové AA, Moon RE. Patent Foramen Ovale-Is It Important to Divers? http://www.diversalertnetwork.org/medical/articles/Patent_Foramen_Ovale_Is_It_Important_to_Divers?
27
Wilmshurst PT, Morrison WL, Walsh KP. Comparison of the size of persistent foramen ovale and atrial septal defects in divers with shunt-related decompression illness and in the general population. Diving Hyperb Med 2015;45:89-93.
28
Sykes O, Clark JE. Patent foramen ovale and scuba diving: a practical guide for physicians on when to refer for screening. Extrem Physiol Med 2013;2:10.
29
UHMS best practice guidelines: prevention and treatment of decompression sickness and arterial gas embolism. http://membership.uhms.org/resource/resmgr/dcsandage_prevandmgt_uhms-fi.pdf.
30
Balestra C, Germonpré P. Correlation between Patent Foramen Ovale, Cerebral “Lesions” and Neuropsychometric Testing in Experienced Sports Divers: Does Diving Damage the Brain? Front Psychol 2016;11:696.
31
Connolly DM, Lee VM. Odds Ratio Meta-Analysis and Increased Prevalence of White Matter Injury in Healthy Divers. Aerosp Med Hum Perform 2015;86:928-35.
32
Schwerzmann M, Seiler C, Lipp E, Guzman R, Lövblad KO, Kraus M, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 2001;134:21-4.
33
Gempp E, Sbardella F, Stephant E, Constantin P, De Maistre S, Louge P, et al. Brain MRI signal abnormalities and right-to-left shunting in asymptomatic military divers. Aviat Space Environ Med 2010;81:1008-12.
34
Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.
35
McGuire SA, Tate DF, Wood J, Sladky JH, McDonald K, Sherman PM, et al. Lower neurocognitive function in U-2 pilots: Relationship to white matter hyperintensities. Neurology 2014;83:638-45.
36
Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP; PICSS Investigators. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke 2004;35:2145-9.
37
Agarwal S, Bajaj NS, Kumbhani DJ, Tuzcu EM, Kapadia SR. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv 2012;5:777-89.
38
Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al; CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012;366:991-9.
39
Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al; RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013;368:1092-100.
40
Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, et al; PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013;368:1083-91.
41
Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-404.
42
Gornall J. A very public break-up. BMJ 2010;340:c110.
43
Mattle HP, Evers S, Hildick-Smith D, Becker WJ, Baumgartner H, Chataway J, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J 2016;37:2029-36.
44
Resmi Gazete. Profesyonel Sualtıadamları Yönetmeliği Sayı: 23098, Sayfa: 16, 02 Eylül 1997. http://www.resmigazete.gov.tr/main.aspx?home=http://www.resmigazete.gov.tr/arsiv/23098.pdf&main=http://www.resmigazete.gov.tr/arsiv/23098.pdf.
45
Türkiye Sualtı Sporları Federasyonu Donanımlı Dalış Talimatı (GSGM Y.T. 20.03.2017. Değişiklik 24.02.2017) https://tssf.gov.tr/yonetmelik-ve-talimatlar/.
46
The medical examination and assessment of divers (MA1). http://www.hse.gov.uk/diving/ma1.pdf.
47
NHS: IPG371 Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers: guidance. http://guidance.nice.org.uk/IPG371/Guidance/ pdf/English.
48
Decompression physiology and susceptibility. http://www.divingmedicine.info/Ch%2013%20 SM10c.pdf.
49
Smart D, Mitchell S, Wilmshurst P, Turner M, Banham N. Joint position statement on persistent foramen ovale (PFO) and diving. South Pacific Underwater Medicine Society (SPUMS) and the United Kingdom Sports Diving Medical Committee (UKSDMC). Diving Hyperb Med 2015;45:129-31.